- Generic name
- Ondansetron
- Strength
- 4 mg/5 ml
- Dosage form
- Syrup
- Manufactured by
- MST Pharma and Healthcare Ltd.
onfast Syrup
About onfast 4 mg/5 ml Syrup
onfast 4 mg/5 ml is a syrup product of MST Pharma and Healthcare Ltd. that contains Ondansetron. It is an anti-emetic medicine that blocks the initiation of the vomiting reflex.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is onfast 4 mg/5 ml Syrup?
Onfast is a syrup from MST Pharma and Healthcare Ltd., with the generic name Ondansetron. It works by blocking a serotonin receptor in the body that starts the vomiting reflex. Onfast syrup contains Ondansetron, a medicine that blocks a substance in the body called serotonin, which can trigger vomiting. Always follow the doctor's instructions and ask a pharmacist if anything is unclear.
Uses of onfast
It is an anti-emetic medicine that blocks the initiation of the vomiting reflex. It is an anti-emetic medicine, meaning it works against vomiting. It does not treat the cancer itself but helps manage these side effects. Your doctor will decide if it is suitable for your situation.
How to use onfast
If you are giving it to a child, follow the doctor's instructions carefully. Measure the liquid with the cap or spoon that comes with the pack. Onfast is taken by mouth. Take onfast exactly as the doctor prescribes. Follow the doctor's instructions and the directions on the label, and ask a pharmacist if anything is unclear.
Side effects of onfast
Headache, constipation and diarrhea are among the more frequently reported side effects, and most are mild or moderate. Rare reports include allergic reactions, wheezing, fast heartbeat, chest pain, low potassium, and shortness of breath. Tell your doctor if you experience any side effect that bothers you or does not go away. Tell your doctor if you notice any side effect, especially one that worries you.
Safety and precautions
It should not be used with apomorphine. Always check with your doctor first if you have other health conditions or take other medicines. Use with caution after abdominal surgery, as it may mask signs of ileus or gastric distension. Your doctor will decide if it is safe for you.
Frequently asked questions
What does onfast treat?
It is an anti-emetic medicine that blocks the initiation of the vomiting reflex. It is an anti-emetic medicine, meaning it works against vomiting.
How is onfast used?
If you are giving it to a child, follow the doctor's instructions carefully. Measure the liquid with the cap or spoon that comes with the pack.
What should I watch for while using onfast?
Headache, constipation and diarrhea are among the more frequently reported side effects, and most are mild or moderate. Rare reports include allergic reactions, wheezing, fast heartbeat, chest pain, low potassium, and shortness of breath.
Is onfast safe for everyone?
It should not be used with apomorphine. Always check with your doctor first if you have other health conditions or take other medicines.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.